A total of 43 patients who recovered from the SARS-CoV-2 infection with mild pneumonia were included along with 45 healthy ...

The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.

Additionally, the prognosis of macular edema may help clinicians evaluate renal function, investigators reported ...

Insights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal ...

Urcosmid is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor, typically found on immune ...

RPESC-RPE-4W is a proprietary retinal pigment epithelium cell therapy for patients with dry age-related macular degeneration.

D-150 is a potential backbone therapy that is designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and ...

The Australian Society of Ophthalmologists (ASO) announces the appointment of Katrina Ronne as its first woman chief ...

Physicians’ Education Resource (PER) has launched Retina Resource, a comprehensive source of education and information on the ...

Researchers set out to determine the age groups for which a polygenic risk score would most effectively predict glaucomatous ...